Clinical practice guideline management of blood borne viruses within the haemodialysis unit

BMC Nephrology

Table 1 Available vaccines, doses and immunisations schedules (1A)

Vaccine Product	Ages	Dose	Schedule (months)
^aEngerix B®	0-15 yrs	10micrograms	0,1,2 and 6–12
^aEngerix B®	11-15 yrs	20micrograms	0 and 6–12^b
Engerix B®	16 yrs. and over	40micrograms	0,1,2 and 6
Fendrix®	15 yrs. and over	20micrograms	0,1,2 and 6
^aHBvaxPro Paediatric®	0-15 yrs.	5micrograms	0,1,2 and 6
HBvaxPro40®	16 yrs. and over	40micrograms	0, 1 and 6

^aAlthough there is experience within the paediatric population of the use of this regime in children aged 0–15, this is strictly outside the product licence
^bIf high risk of acquiring infection with HBV during vaccination course, 3 dose or accelerated schedule as per manufacturer guidelines, should be used

ISSN: 1471-2369